Understanding How Immune Cells Respond to Severe Injuries

Neutrophils in polytrauma – from recruitment to phenotypic and functional reprogramming

NIH-funded research Albert Einstein College of Medicine · NIH-11120854

This project looks at how immune cells called neutrophils react to severe injuries, especially in people who also have ongoing low-level inflammation.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine NIH-funded
Lab location1 site (Bronx, United States)
Project IDNIH-11120854 on NIH RePORTER

What this research studies

This research aims to understand how neutrophils, a type of immune cell, respond to severe traumatic injuries. It focuses on how these responses might be different in people who also have chronic low-grade inflammation, sometimes called "metabolic" inflammation. Researchers want to learn how this underlying inflammation changes neutrophil behavior, which can make patients more vulnerable to serious complications like infections and organ failure after trauma. By uncovering these specific mechanisms, the project hopes to find ways to improve recovery and reduce life-threatening situations for patients with severe injuries.

Who could benefit from this research

Good fit: This research is relevant to patients who experience severe traumatic injuries, especially those who also have chronic low-grade systemic inflammation.

Not a fit: Patients without severe traumatic injuries or chronic low-grade systemic inflammation would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies to prevent complications like sepsis and organ failure in trauma patients, particularly those with underlying inflammation.

How similar studies have performed: While the role of neutrophils in trauma is known, understanding how chronic inflammation specifically impacts their response in polytrauma is an area with limited current knowledge, suggesting this approach is novel.

Where this research is happening

Bronx, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.